Roger Jeffs

Director · Liquidia

Roger Jeffs (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $4.6M of LQDA (75,000 sh across 3 lots, as filed), executed May 21. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 13 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$32.2M

shares × price, as filed

Last traded

Oct 12

Filed Oct 13

Median ADV $143.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $47.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 13 filings

Sector per market data · by filing · past 12 months

Most traded names

LQDA Liquidia Corporation LQDA · 0 buys · 19 sells 19 filings AXSM

Axsome Therapeutics, Inc. AXSM · 0 buys · 3 sells 3 filings

Recent filings

AXSMSALE Axsome Therapeutics, Inc. View filing → $4.4M
36,694 sh across 2 lots
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $289K
20,252 sh × $14.28
Exec Jul 14 2025
Filed Jul 15 2025 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $289K
20,252 sh × $14.28
Exec Jul 14 2025
Filed Jul 15 2025 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $519K
30,610 sh × $16.97
Exec Jun 4 2025
Filed Jun 5 2025 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $192K
14,130 sh × $13.57
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $263K
22,343 sh × $11.78
Exec Jan 14 2025
Filed Jan 14 2025 · 5:30 PM ET